There are two different storms brewing in the pharmaceutical world. On the one hand there is increasing opposition to the very high prices of drugs. On the other hand there is ever more pressure to accelerate access to drugs for seriously ill patients
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/03/20/a-better-balance-between-accelerated-access-and-high-priced-new-drugs-a-new-conditional-approval-option/
Posted
Mar 20 2017, 08:51 AM
by
Health Affairs BlogHealth Affairs Blog